Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06310915
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-03-05
Brief Title:
Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally AdvancedAdvanced Non-small Cell Lung Cancer With PS Score 2 A Prospective Single-arm Multicenter Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor
Sponsor:
Guangzhou Institute of Respiratory Disease
Organization:
Guangzhou Institute of Respiratory Disease
Study Overview
Official Title:
This Study is a Pilot Study in Driver-negative Locally AdvancedLate-stage Nonsmall Cell Lung Cancer With ECOG PS2 Analysing the Efficacy Safety and Efficacy of Oral Chemotherapy in Combination With PD-1 Inhibitors and Safety of Oral Chemotherapy in Combination With PD-1 Inhibitors in Patients With Locally AdvancedAdvanced Non-cellular Lung Cancer withECOG PS2This is a Prospective Single-arm Multicentre Observational Study
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Oral chemotherapeutic drugs were analyzed in patients with driver gene negative locally advancedadvanced non-small cell lung cancer with PS score 2 A prospective single-arm multicenter observational study on the efficacy and safety of radiochemotherapy combined with PD-1 inhibitor
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None